Kinins and chymase: the forgotten components of the renin-angiotensin system and their implications in COVID-19 disease

Z Abassi, K Skorecki, DB Hamo-Giladi… - … of Physiology-Lung …, 2021 - journals.physiology.org
Z Abassi, K Skorecki, DB Hamo-Giladi, E Kruzel-Davila, SN Heyman
American Journal of Physiology-Lung Cellular and Molecular …, 2021journals.physiology.org
The unique clinical features of COVID-19 disease present a formidable challenge in the
understanding of its pathogenesis. Within a very short time, our knowledge regarding basic
physiological pathways that participate in SARS-CoV-2 invasion and subsequent organ
damage have been dramatically expanded. In particular, we now better understand the
complexity of the renin-angiotensin-aldosterone system (RAAS) and the important role of
angiotensin converting enzyme (ACE)-2 in viral binding. Furthermore, the critical role of its …
The unique clinical features of COVID-19 disease present a formidable challenge in the understanding of its pathogenesis. Within a very short time, our knowledge regarding basic physiological pathways that participate in SARS-CoV-2 invasion and subsequent organ damage have been dramatically expanded. In particular, we now better understand the complexity of the renin-angiotensin-aldosterone system (RAAS) and the important role of angiotensin converting enzyme (ACE)-2 in viral binding. Furthermore, the critical role of its major product, angiotensin (Ang)-(1–7), in maintaining microcirculatory balance and in the control of activated proinflammatory and procoagulant pathways, generated in this disease, have been largely clarified. The kallikrein-bradykinin (BK) system and chymase are intensively interwoven with RAAS through many pathways with complex reciprocal interactions. Yet, so far, very little attention has been paid to a possible role of these physiological pathways in the pathogenesis of COVID-19 disease, even though BK and chymase exert many physiological changes characteristic to this disorder. Herein, we outline the current knowledge regarding the reciprocal interactions of RAAS, BK, and chymase that are probably turned-on in COVID-19 disease and participate in its clinical features. Interventions affecting these systems, such as the inhibition of chymase or blocking BKB1R/BKB2R, might be explored as potential novel therapeutic strategies in this devastating disorder.
American Physiological Society